About Synerlab
Synerlab is a Healthcare company based in Erstein (France) founded in 2000, and was acquired by Blue Wolf Capital Partners in October 2024. Contract development and manufacturing organization. Synerlab has completed 2 acquisitions, including Alcal Farma and Lyofal. Synerlab offers products and services including Lyophilisation Services, Sterile Multidose Services, Formulation Development, Packaging Services, and Regulatory Affairs. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Synerlab was founded in 2000 in Erstein, France, as a contract development and manufacturing organization. Operations focus on the pharmaceutical, dietetic, veterinary, and dietary supplements sectors. Solid oral dosage forms are developed, manufacturing processes are handled, and custom packaging is offered to meet market needs. The company supports various clients through these specialized services in a regulated environment.
- Headquarters Erstein, France
- Stage Acquired
- SectorsHealthcare
- Website synerlab.com
- Social LinkedIn
- Acquired by 21 Invest (Nov 2013)
- Latest Funding Round$603.85K (USD), Grant
Jan 2021
- Investors
- Investments & AcquisitionsAlcal Farma
& 1 more
- Acquired by
Products & Services of Synerlab
Synerlab offers a comprehensive portfolio of products and services, including Lyophilisation Services, Sterile Multidose Services, Formulation Development, Packaging Services, and Regulatory Affairs.
Freeze-drying services for pharmaceutical products and stability.
Expert manufacturing of sterile multidose formulations.
Analytical and process development for new drug formulations.
Tailored packaging solutions for various dosage forms.
Support for navigating EU pharmaceutical regulations.
Funding Insights of Synerlab
- Total Rounds 5
- Last Round Grant — $603,850
- Investors Count 3
All 5 funding rounds of Synerlab with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $603,850 | Grant | – | – | |
| Jul 2017 | Debt – Conventional | – | – | – | |
| Dec 2013 | Debt – Conventional | – | – | ||
| Jun 2007 | Private Equity Round | – | – | ||
| Jun 2003 | Seed | – | – |
5 investors in total: 5 institutional.
Investors in Synerlab
Synerlab has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Ministry of Economy, Finance and Industrial and Digital Sovereignty, Ardian and Naxicap.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private investment firm specializing in markets and partnerships. | ardian.com | |||
Investments in small and medium-sized businesses are managed by Naxicap. | naxicap.com | Frankfurt Am Main, Germany | ||
Private equity investments in Europe are managed by the firm. | bluewolfcapital.com | New York, United States | ||
Companies are supported through investments for growth by 21 Invest. | 1992 | 21invest.com | Treviso, Italy | |
| economie.gouv.fr |
Investor details for Synerlab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synerlab
Synerlab has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Alcal Farma and Lyofal.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
CDMO for OTC products and food supplements. | alcala-farma.es | 1995 | Nov 2015 | •••• | ||
Online offering natural products | lyofal.fr | France | 2022 | Nov 2012 | •••• |
Complete acquisition details for Synerlab
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Synerlab
7 dated milestones of Synerlab across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Synerlab is founded.
- Funding First funding round.
- Acquisition Acquires Lyofal.
- Exit Acquired by 21 Invest.
- Acquisition Acquires Alcal Farma.
- Funding Latest funding round, Grant, of $604K.
- Exit Acquired by Blue Wolf Capital Partners.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Synerlab
Complete news archive for Synerlab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synerlab
Synerlab was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Synerlab is headquartered in Erstein, France. It is registered at Erstein, Bas-rhin, France.
Synerlab was founded in 2000 in Erstein, France, as a contract development and manufacturing organization. Operations focus on the pharmaceutical, dietetic, veterinary, and dietary supplements sectors. Solid oral dosage forms are developed, manufacturing processes are handled, and custom packaging is offered to meet market needs. The company supports various clients through these specialized services in a regulated environment.
Synerlab offers Lyophilisation Services, Sterile Multidose Services, Formulation Development, Packaging Services, and Regulatory Affairs.
Synerlab has made 2 acquisitions, including Alcal Farma, and Lyofal.
Synerlab has 5 investors. Key investors include Ministry of Economy, Finance and Industrial and Digital Sovereignty, Ardian, Naxicap, Blue Wolf Capital Partners, and 21 Invest.
Yes. Synerlab was acquired by 21 Invest in November 2013.